| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/30/1997 | US5672489 Catalytic antibodies hydrolyzing acylated carbohydrates in a regioselective and stereoselective manner |
| 09/30/1997 | US5672488 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 09/30/1997 | US5672487 Transformation yeast with an expression cassette polypeptide sequence comprising a leader of a neurohormone, an adaptor producing an alpha-helix structure, a processing signal and a structural gene |
| 09/30/1997 | US5672486 Protein polyligands joined to a stable protein core |
| 09/30/1997 | US5672485 Immortalized cell lines for virus growth |
| 09/30/1997 | US5672477 Streptococcus lactis plasmid encoding for mucoidness |
| 09/30/1997 | US5672473 Methods of identifying compounds useful for treating autoimmune diseases |
| 09/30/1997 | US5672372 Method for sweetening a food composition with single-chain monellin analogs |
| 09/30/1997 | US5672345 Stable genetic engineered vaccines |
| 09/30/1997 | US5672344 Viral-mediated gene transfer system |
| 09/30/1997 | US5672343 N- 3 deletion mutants of the long form of CSF-1 |
| 09/30/1997 | US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected |
| 09/30/1997 | CA2177217A1 Compositions and methods for production of male-sterile plants |
| 09/29/1997 | CA2201216A1 Human lens epithelial cell line |
| 09/25/1997 | WO1997035449A2 Fixed wireless terminals in network management method and apparatus |
| 09/25/1997 | WO1997035204A1 Method for predicting the outcome of hepatitis b infection |
| 09/25/1997 | WO1997035200A1 Super-paramagnetic particles with increased r1 relaxivity, processes for producing said particles and use thereof |
| 09/25/1997 | WO1997035198A1 Methods for spatially-dispersed positionally-encoded combinatorial library synthesis |
| 09/25/1997 | WO1997035197A1 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
| 09/25/1997 | WO1997035196A1 Engineering affinity ligands for macromolecules |
| 09/25/1997 | WO1997035194A2 Enantiomeric screening process, and compositions therefor |
| 09/25/1997 | WO1997035037A1 Tissue remodeling proteins |
| 09/25/1997 | WO1997035036A1 Methods of screening for a tumor or tumor progression to the metastatic state |
| 09/25/1997 | WO1997035032A1 Method for molecular diagnosis of tumor angiogenesis and metastasis |
| 09/25/1997 | WO1997035026A1 Target nucleic acid sequence amplification |
| 09/25/1997 | WO1997035024A1 Enzyme combinations for destroying proliferative cells |
| 09/25/1997 | WO1997035023A2 Alteration of amino acid compositions in seeds |
| 09/25/1997 | WO1997035022A1 Export systems for recombinant proteins |
| 09/25/1997 | WO1997035021A2 Prostate specific antigen oligo-epitope peptide |
| 09/25/1997 | WO1997035020A1 Mch4 AND Mch5, APOPTOTIC PROTEASE, NUCLEIC ACIDS ENCODING AND METHODS OF USE |
| 09/25/1997 | WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells |
| 09/25/1997 | WO1997035018A1 Growth factor inducible serine/threonine phosphatase fin13 |
| 09/25/1997 | WO1997035017A1 Polypeptides having phytase activity and nucleic acids encoding same |
| 09/25/1997 | WO1997035016A1 Polypeptides having phytase activity and nucleic acids encoding same |
| 09/25/1997 | WO1997035015A2 Tyrosine-phosphatase-related protein |
| 09/25/1997 | WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a) |
| 09/25/1997 | WO1997035013A1 PROCESS FOR INCREASING THE PRODUCTION OF PENICILLIN G (BENZYLPENICILLIN) IN PENICILLIUM CHRYSOGENUM THROUGH THE EXPRESSION OF THE GENE pcl |
| 09/25/1997 | WO1997035012A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | WO1997035011A1 Recombinant process for the production in pseudomonas putida of the cytochrome c551 of pseudomonas aeruginosa |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997035009A1 Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 09/25/1997 | WO1997035008A1 Methods and compositions of chimeric polypeptides for tumor antigen vaccines |
| 09/25/1997 | WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | WO1997035006A1 Human cell death-associated protein |
| 09/25/1997 | WO1997035005A2 Cftr gene regulator |
| 09/25/1997 | WO1997035004A1 Cell stimulation |
| 09/25/1997 | WO1997035003A1 Selective expression of desired genes in cells expressing oncoproteins |
| 09/25/1997 | WO1997035002A1 Purification of pharmaceutical-grade plasmid dna |
| 09/25/1997 | WO1997035001A1 Fungal gene encoding resistance to the phytotoxin cercosporin |
| 09/25/1997 | WO1997034998A1 Human cytokine polypeptide |
| 09/25/1997 | WO1997034996A2 Induction quiescence in bacterial cells and uses thereof |
| 09/25/1997 | WO1997034931A1 Antibody specific for staphylococcus aureus, and use thereof |
| 09/25/1997 | WO1997034927A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/25/1997 | WO1997034926A2 Bacillus thuringiensis genes encoding nematode-active toxins |
| 09/25/1997 | WO1997034915A1 Molecule and method for importing dna into a nucleus |
| 09/25/1997 | WO1997034914A1 Compositions for the diagnosis and treatment of chediak-higashi syndrome |
| 09/25/1997 | WO1997034912A1 Directed switch-mediated dna recombination |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034909A1 Nucleic acid isolation |
| 09/25/1997 | WO1997034908A1 Process and device for isolating nucleic acids |
| 09/25/1997 | WO1997034641A1 Stat6 deficient transgenic animals |
| 09/25/1997 | WO1997034638A1 Antisense approach to gene inhibition |
| 09/25/1997 | WO1997034636A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/25/1997 | WO1997034634A1 Single chain fv constructs of anti-ganglioside gd2 antibodies |
| 09/25/1997 | WO1997034632A1 Glycosylated humanized b-cell specific antibodies |
| 09/25/1997 | WO1997034631A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | WO1997034629A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | WO1997034626A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997034618A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034483A1 Methods for increasing or decreasing transfection efficiency |
| 09/25/1997 | WO1997031116A3 Recombinant ribonuclease proteins |
| 09/25/1997 | WO1997031112A3 Compounds and related methods for modulating potassium ion channels and assays for such compounds |
| 09/25/1997 | WO1997030024A3 Lipids and their use, for example, in liposomes |
| 09/25/1997 | WO1997025441A3 Process for detecting and quantifying nucleic acid molecules |
| 09/25/1997 | WO1997023630A3 Polyketide-associated sugar biosynthesis genes |
| 09/25/1997 | WO1997022363A3 Improved pharmaceutical compositions |
| 09/25/1997 | WO1997020048A3 Modified SFV molecules which mediate adhesion between cells and uses thereof |
| 09/25/1997 | WO1997020031A3 Rna polymerase ii carboxyl terminal domain-derived peptides |
| 09/25/1997 | WO1997019178A3 Autoantigenic metal proteases and methods of diagnosing autoimmune diseases |
| 09/25/1997 | WO1997019113A3 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 09/25/1997 | WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/25/1997 | WO1997015584A3 Use of linalool synthase in genetic engineering of scent production |
| 09/25/1997 | WO1997012043A3 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 09/25/1997 | WO1997008317A3 Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof |
| 09/25/1997 | DE19634159C1 Hybrid cells prepared by fusing malignant B cells with hybridoma that expresses antibodies |
| 09/25/1997 | DE19612001A1 Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung Superparamagnetic particles with increased relaxivity R¶1¶, methods of preparation and use thereof |
| 09/25/1997 | DE19610805A1 Transfection of eukaryotic cells |
| 09/25/1997 | CA2257343A1 Fungal gene encoding resistance to the phytotoxin cercosporin |
| 09/25/1997 | CA2250222A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | CA2250076A1 Method for predicting the outcome of hepatitis b infection |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249994A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | CA2249717A1 Target nucleic acid sequence amplification |
| 09/25/1997 | CA2249618A1 Method for molecular diagnosis of tumor angiogenesis and metastasis |
| 09/25/1997 | CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha. |
| 09/25/1997 | CA2249465A1 Purification of pharmaceutical-grade plasmid dna |
| 09/25/1997 | CA2249419A1 Methods for spatially-dispersed positionally-encoded combinatorial library synthesis |
| 09/25/1997 | CA2249368A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | CA2249306A1 Methods of screening for a tumor or tumor progression to the metastatic state |